Where can I learn more about this study?
You can find more information about this study on the websites listed below. If
more information about the study results is available, it can also be found here.
X www.clinicaltrials.gov. Once you are on the website, type “NCT04380688”
into the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D822FC00003” into the search box, and click “Find a Study”.
Full Study Title: A Phase 2, Open Label, Randomized Study of the Efficacy and
Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in
Subjects Hospitalized with COVID-19
Acerta Pharma B.V. Protocol Number: D822FC00003
National Clinical Trials Number: NCT04380688
Acerta Pharma B.V. sponsored this study and has its headquarters at Oss,
The Netherlands.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants and their families belong to a large community of
people who take part in clinical research around the world. They help researchers
answer important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about clinical research participation. CISCRP is not
involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_08_30
12 | Clinical Study Results